ALTACE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Ramipril.
| Product ID | 61570-120_7c58ba31-97ac-4b94-93c7-d6c9868df832 |
| NDC | 61570-120 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ALTACE |
| Generic Name | Ramipril |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 1991-01-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019901 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | RAMIPRIL |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 1991-01-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019901 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1991-01-28 |
| Marketing End Date | 2011-07-31 |
| Marketing Category | NDA |
| Application Number | NDA019901 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1991-01-28 |
| Ingredient | Strength |
|---|---|
| RAMIPRIL | 10 mg/1 |
| SPL SET ID: | 0fc34cd8-86e6-4034-73bd-4263a68ba046 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 61570-120 | ALTACE | ALTACE |
| 61570-110 | ALTACE | ALTACE |
| 61570-112 | ALTACE | ALTACE |
| 61570-111 | ALTACE | ALTACE |
| 0054-0106 | Ramipril | Ramipril |
| 0054-0107 | Ramipril | Ramipril |
| 0054-0108 | Ramipril | Ramipril |
| 0054-0109 | Ramipril | Ramipril |
| 10544-588 | Ramipril | Ramipril |
| 16729-152 | Ramipril | Ramipril |
| 16729-153 | Ramipril | Ramipril |
| 16729-154 | Ramipril | Ramipril |
| 16729-155 | Ramipril | Ramipril |
| 17856-0108 | RAMIPRIL | RAMIPRIL |
| 21695-821 | Ramipril | ramipril |
| 21695-822 | Ramipril | ramipril |
| 21695-823 | Ramipril | ramipril |
| 31722-271 | Ramipril | Ramipril |
| 31722-272 | Ramipril | Ramipril |
| 31722-273 | Ramipril | Ramipril |
| 31722-274 | Ramipril | Ramipril |
| 33261-903 | Ramipril | Ramipril |
| 33261-967 | Ramipril | Ramipril |
| 42291-692 | Ramipril | Ramipril |
| 43063-303 | Ramipril | Ramipril |
| 43063-502 | Ramipril | Ramipril |
| 45865-441 | Ramipril | Ramipril |
| 45865-443 | Ramipril | Ramipril |
| 50090-1118 | Ramipril | Ramipril |
| 50090-1120 | Ramipril | Ramipril |
| 50090-1354 | Ramipril | Ramipril |
| 50090-2169 | Ramipril | Ramipril |
| 50090-2577 | Ramipril | Ramipril |
| 50090-3059 | Ramipril | Ramipril |
| 50090-3873 | Ramipril | Ramipril |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ALTACE 76171261 2552254 Dead/Cancelled |
King Pharmaceuticals, Inc. 2000-11-27 |
![]() ALTACE 74092062 1812659 Live/Registered |
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, LLC 1990-08-28 |